 |
A Publication of the James Buchanan Brady
Urological Institute Johns Hopkins Medical Institutions
Volume VI, Winter 2003
Racemase: A New Marker for Cancer, and More
Men
who consume large amounts of dairy products or red meat are more
likely to develop metastatic prostate cancer and to die of the disease.
What De Marzo (left), Issacs and colleagues are learning about racemase
may help explain why.
|
|
|
|
Have you ever seen an operator’s switchboard? If
it’s “prime time” and many people are talking on the telephone
at once, it can be a dazzling array of lights; after hours, the
lights may be few and far between. This is the general concept
of a gene chip, except the “lights,” or lack of them, are really
fluorescent-dyed copies of RNA, the switchboard is a glass slide
that’s half the size of a credit card, and the super-fast operator
can handle more than 10,000 calls—in this case, each dyed- RNA
dot represents a separate gene—at a time. All the information
is then read on a scanner about the size of a laser printer.
The microarray technology was a gift from the Peter
Sharp Foundation, and Brady molecular geneticist William Isaacs,
Ph.D., and colleagues are using it to troll through the human
genome, looking to see which genes are expressed differently in
men with prostate cancer. (Note: This is different from Isaacs’
other search for genes linked to inherited prostate cancer;
read
story). With Jeffrey Trent, Ph.D., and colleagues
at the National Institutes of Health, Jun Luo, Ph.D., a Brady
research scientist, and technician Tom Dun, Isaacs set up the
microarray—like a telemarketer making random “cold calls”– to
look for “hits,” genes that are expressed differently in normal
and cancerous prostate cells.
And bingo—out of these studies came a gene from
nowhere, one nobody even thought of in connection with prostate
cancer, called a methylacyl CoA racemase (AMACR, or racemase for
short). Next Isaacs turned to pathologist Angelo De Marzo, M.D.,
Ph.D., who also has expertise in molecular genetics, to figure
out what racemase may have to do with prostate cancer.
In an elegant series of studies, De Marzo demonstrated
that production of racemase is turned up in both prostate cancer
and in high-grade PIN (abnormal cells that are not yet cancerous,
but considered a pre-curser to cancer)—but not in normal prostate
tissue. As a result of this work, De Marzo says, “we think we
have a new marker for prostate cancer. This is one of the most
consistently upregulated genes in prostate cancer. It gets turned
up early in the process of cancer formation, and it stays up even
in men who are failing hormonal therapy. This might be something
we could start using right away, to help us diagnose prostate
cancer in difficult cases.” He is working with pathologist Jonathan
Epstein, M.D., to see whether looking for higher-than-normal levels
of racemase can improve the diagnosis of prostate cancer on a
needle biopsy.
“We have every indication that this is going to
work,” says Isaacs. “There is going to be a gene expression profile
which correlates with high Gleason grade.” He and De Marzo also
are working to create a “molecular definition” that will help
predict what a man’s cancer will do. For example, says Isaacs,
“with men who have a Gleason 6 or 7 prostate cancer, some are
going to progress, and some aren’t.”
|
Bingo.
Out of these studies came a gene from nowhere, one nobody
even thought of in connection with prostate cancer. |
Racemase and Diet
But using racemase as a marker for cancer
is just the proverbial tip of the iceberg, say De Marzo and Isaacs.
Racemase itself is not a “new” gene; scientists
have known for years that it plays a key role in the body’s metabolism
of fatty acids. It makes an enzyme that “takes branch-chain fatty
acids, which are found in dairy products and red meat, and converts
them to a form that we can burn as energy,” says De Marzo. But
the fatty acids in question are very specific, adds Isaacs. “You
don’t need this enzyme for most fatty acids. However, you do need
it to metabolize a type of fatty acid that’s particularly prominent
in dairy products.” This acid, called phytanic acid, comes from
phytol, which in turn is derived from chlorophyll. Which means,
Isaacs explains, “that animals that eat a lot of grass end up
incorporating a lot of phytanic acid into their milk and meat.”
Think cows, and think—as De Marzo and Isaacs are thinking, with
growing excitement—of the known links between red meat and dairy
products and prostate cancer.
Scientists have known for several years that
men who consume large amounts of dairy products or red meat are
more likely to develop metastatic prostate cancer, and to die
of the disease.
“This
may be the best scientific evidence to support the concept
that dietary factors influence the growth of prostate cancer.” |
What De Marzo, Isaacs, and colleagues are learning
about racemase may help explain why. Racemase is expressed nine
times higher in prostate cancer than in normal tissue. This means
that when men with prostate cancer eat red meat or dairy products,
the cancer cells have the potential to gain and use more energy
from these foods than normal cells can. And something else happens,
too: When the body metabolizes phytanic acid, it makes a toxic
byproduct—hydrogen peroxide. “Right now it’s complete speculation,
but this may turn out to increase oxidative stress in the cell,”
says Isaacs. Oxidative damage is incremental harm, caused over
many years, as free radicals—a harmful result of everyday metabolism—
attack the DNA in cells, causing mutations that lead to cancer,
or cause it to progress.
For years, there has been increasing scientific
speculation on the role diet may play in preventing progression
of prostate cancer. Says Urologist-in-chief Patrick C. Walsh,
M.D.: “This may be the best scientific evidence to support the
concept that dietary factors influence the growth of prostate
cancer. I am impressed enough by these data to use them in making
recommendations to patients. I tell men who are considering watchful
waiting, or who have PSA progression after surgery or radiation
therapy that they should markedly limit their intake of red meat
and dairy products.” (Fat-free milk is fine, Walsh adds.)
And the microarrays launched it all. “Here’s a
gene that we never would have thought about ordinarily,” says
Isaacs. “We were not even aware of this pathway, or phytanic acid,
or what any of these things were, and here’s this gene that comes
screaming up on our arrays. This not only gives us a new marker
for prostate cancer —it may give us some insight into the mechanisms
by which normal prostate cells convert to cancer cells. And perhaps
it could prove this idea that reducing dairy products in the diet
may be an important way to prevent or slow the progression of
prostate cancer.”
|
|
 |
 |